Cross-Sector entity
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention 4D Medical, the most common co-covered peer. The tracked stories average 5 original sources each. Tim Boreham appears in 1 tracked Cross-Sector story from February 25, 2026.
1 verified story tracked
Last mentioned: Feb 25, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention 4D Medical, the most common co-covered peer. The tracked stories average 5 original sources each. Tim Boreham appears in 1 tracked Cross-Sector story from February 25, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Tim Boreham. Shared-story counts are live from our verified record — not editorial picks.
The global healthcare sector is bifurcating as mid-cap biotech innovators outperform established heavyweights despite regulatory headwinds from the Trump administration. While the ASX 200 healthcare index fell 25% in 2025, a surge in capital raising and AI integration is fueling a resilient 'engine room' of drug discovery and device innovation.
Source: 0 Comments (au) · 0 Comments (au)
